Dominick Joseph Angiolillo

University of Florida College of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (6)

Alexander Fanaroff

Assistant Professor of Medicine

University of Pennsylvania

UNITED STATES

View details

Antonio Greco

University of Catania

ITALY

View details

Fabio M. Pulcinelli

Sapienza University of Rome

ITALY

View details

David Schneider

Professor

University of Vermont

UNITED STATES

View details

Luis Ortega-Paz

Assistant professor of Medicine

University of Florida

UNITED STATES

View details

Paolo Calabrò

University of Campania “Luigi Vanvitelli”

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dominick Joseph Angiolillo

Research Interests

Explore related searches

Contact this professor

Articles (21)

Predictive Value of Platelet FcγRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial Infarction

Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis

Direct oral anticoagulants in stroke prevention of atrial fibrillation patients: can we rely on them in all clinical scenarios?

Ticagrelor Therapy Modifications after Acute Coronary Syndrome: An Ever-Evolving Issue

Deciphering the Role of In-hospital Bleeding in Acute Coronary Syndromes

Editorial: Navigating the complexity of bleeding and hypercoagulable disorders in patients with acute myocardial infarction

Dynamics of Thrombogenicity and Platelet Function and Correlation with Bleeding Risk in Patients Undergoing M-TEER Using the PASCAL System

Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital

Switching from cangrelor to oral P2Y 12 inhibitors: a focused review on drug-drug interactions

Therapeutic Potential of FXI Inhibitors: Hype or Hope?

Bleeding in acute coronary syndrome: from definitions, incidence, and prognosis to prevention and management

Personalised antiplatelet therapies for coronary artery disease: what the future holds

Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromes

Correction to: Clinical Pharmacokinetics and Pharmacodynamics of CSL112

How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention?

Clinical Pharmacokinetics and Pharmacodynamics of CSL112

Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy

Efficacy and safety of lidocaine vs. opioid analgesics in acute coronary syndromes

Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot.

Collaborators (6)

Alexander Fanaroff

Antonio Greco

Fabio M. Pulcinelli

David Schneider

Luis Ortega-Paz

Paolo Calabrò

Make your next move.